# EDGAR Filing Document

**Accession Number:** 0001396092
**File Stem:** 0001396092-26-000169
**Filing Date:** 2026-3
**Character Count:** 16943
**Document Hash:** 8668acb0c4c20f4ff01ee4ae4eea5378
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001396092-26-000169.hdr.sgml**: 20260302

**ACCESSION NUMBER**: 0001396092-26-000169

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260302

**DATE AS OF CHANGE**: 20260302

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** World Funds Trust
- **CENTRAL INDEX KEY:** 0001396092

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22172
- **FILM NUMBER:** 26706475

**BUSINESS ADDRESS:**
- **STREET 1:** 8730 STONY POINT PARKWAY
- **STREET 2:** SUITE 205
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235
- **BUSINESS PHONE:** 804-267-7400

**MAIL ADDRESS:**
- **STREET 1:** 8730 STONY POINT PARKWAY
- **STREET 2:** SUITE 205
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Abacus World Funds Trust
- **DATE OF NAME CHANGE:** 20070410

## Series and Classes Contracts Data

### Perkins Discovery Fund (Series ID: S000038882)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000119646 | Investor     | PDFDX           |

## Nport-Ex

**PERKINS DISCOVERY FUND**

**Schedule of Investments**

**December 31, 2025 (unaudited)**

---

| | | | |
|:---|:---|:---|:---|
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;&nbsp;&nbsp;**Value** |
| **99.54%** | **COMMON STOCKS** |  |  |
| **99.54%** | **COMMON STOCKS** |  |  |
| **13.80%** | **BIOTECHNOLOGY** |  |  |
|  | Elutia, Inc. <sup>(A)</sup> | 37500 | $25976 |
|  | MDxHealth SA<sup>(A)</sup> | 32500 | 116025 |
|  | Veracyte, Inc. <sup>(A)</sup> | 14000 | 589400 |
|  | Vericel Corp.<sup>(A)</sup> | 6000 | 216060 |
|  |  |  | 947461 |
| **6.33%** | **CONSUMER DISCRETIONARY** |  |  |
|  | Magnite, Inc. <sup>(A)</sup> | 20000 | 324600 |
|  | Perion Network Ltd.<sup>(A)</sup> | 11500 | 110170 |
|  |  |  | 434770 |
| **15.64%** | **HEALTH CARE DRUGS/SERVICES** |  |  |
|  | ANI Pharmaceuticals, Inc. <sup>(A)</sup> | 6350 | 501269 |
|  | Cryoport, Inc. <sup>(A)</sup> | 15000 | 144000 |
|  | NeoGenomics, Inc. <sup>(A)</sup> | 22000 | 258720 |
|  | Owlet, Inc. <sup>(A)</sup> | 10500 | 169995 |
|  |  |  | 1073984 |
| **4.03%** | **HEALTH CARE MANUFACTURING** |  |  |
|  | AtriCure, Inc. <sup>(A)</sup> | 7000 | 276920 |
| **19.70%** | **HEALTH CARE SUPPLIES** |  |  |
|  | Axogen, Inc.<sup>(A)</sup> | 27000 | 883710 |
|  | BioLife Solutions, Inc.<sup>(A)</sup> | 12500 | 302250 |
|  | Exagen, Inc. <sup>(A)</sup> | 15000 | 91200 |
|  | TELA Bio, Inc.<sup>(A)</sup> | 64000 | 75520 |
|  |  |  | 1352680 |
| **10.84%** | **HEALTH CARE SUPPORT** |  |  |
|  | Natera, Inc. <sup>(A)</sup> | 37570 | 744543 |

---

**PERKINS DISCOVERY FUND**

**Schedule of Investments**

**December 31, 2025 (unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | &nbsp;&nbsp;**Shares** |  | &nbsp;&nbsp;&nbsp;&nbsp;**Value** |
| **8.59%** | **HEALTH CARE TECHNOLOGY** |  |  |  |
|  | Butterfly Network,¬Inc. <sup>(A)</sup> | 60500 | $ | $229900 |
|  | OptimizeRX Corp.<sup>(A)</sup> | 14000 |  | 171640 |
|  | Tactile Systems Technology, Inc.<sup>(A)</sup> | 6500 |  | 188500 |
|  |  |  |  | 590040 |
| **8.97%** | **INFORMATION TECHNOLOGY** |  |  |  |
|  | Digi International, Inc. <sup>(A)</sup> | 6000 |  | 259740 |
|  | Inuvo, Inc. <sup>(A)</sup> | 37500 |  | 93000 |
|  | SkyWater Technology, Inc. <sup>(A)</sup> | 14500 |  | 263320 |
|  |  |  |  | 616060 |
| **11.64%** | **SOFTWARE SERVICES** |  |  |  |
|  | Asure Software, Inc. <sup>(A)</sup> | 23500 |  | 221370 |
|  | Backblaze, Inc.<sup>(A)</sup> | 30000 |  | 139800 |
|  | ePlus, Inc.<sup>(A)</sup> | 5000 |  | 438500 |
|  |  |  |  | 799670 |
| **99.54%** | **TOTAL COMMON STOCKS** |  |  | 6836128 |
|  | (Cost: $2,943,473) |  |  |  |
|  | (Cost: $2,943,473) |  |  |  |
| **0.52%** | **MONEY MARKET FUND** |  |  |  |
|  | Fidelity Government Portfolio(A) 3.670% | 35693 |  | 35693 |
|  | (Cost: $35,693) |  |  | 6871821 |
| **100.06%** | **TOTAL INVESTMENTS** |  |  | 6871821 |
|  | (Cost: $2,979,166) |  |  |  |
| **(0.06%)** | Liabilities in excess of other assets |  |  | (4288) |
| **100.00%** | **NET ASSETS** |  |  |  |
| **100.00%** | **NET ASSETS** |  |  | $**6867533** |

---

(A)Non-income producing

(B)Effective 7 day yield as of December 31, 2025<sup>.</sup>

In accordance with U.S. GAAP, "fair value" is defined as the price that a Fund would receive upon selling an investment in an orderly transaction to an independent buyer in the principal or most advantageous market for the investment. Various inputs are used in in determining the value of a Fund's investments. U.S. GAAP established a three-tier hierarchy of inputs to establish a classification of fair value measurements for disclosure purposes. Level 1 includes quoted prces in active markets for identical securities.

Level 2 includes other significant observable inputs (including quoted prices for similar securities, interet rates, prepayment speeds, credit, risk, etc.). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following summarizes the inputs used to value the Fund's investments as of December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Level 1 | Level 2 | Level 3 |  |
|  | <br>Quoted Prices | Other<br>Significant<br>Observable Inputs | Significant<br>Unobservable<br>Inputs | <br>Total |
| COMMON STOCKS | $6836128 | $- | $- | $6836128 |
| MONEY MARKET FUND | 35693 | - | - | 35693 |
| TOTAL INVESTMENTS | $6871821 | $- | $- | $6871821 |

---

The cost of investments for Federal income tax purposes has been estimated a/o December 31, 2025 since the final tax characteristics cannot be determined until fiscal year end. Cost of securities for Federal income tax purpose is $2,979,166, and the related net unrealized appreciation (depreciation) consists of:

---

| | |
|:---|:---|
| Gross unrealized appreciation | $4435867 |
| Gross unrealized depreciation | (543212) |
| &nbsp;&nbsp;Net unrealized appreciation | $3892655 |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** World Funds Trust

- **b. Investment Company Act file number:** 811-22172

- **c. CIK number of Registrant:** 0001396092

- **d. LEI of Registrant:** 5493007BOSPYEMKSSY03

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 8730 Stony Point Parkway

  - **City:** Richmond

  - **State:** VA

  - **Foreign country:** US

  - **Zip / Postal Code:** 23235

  - **Telephone number:** 800-673-0550

**Item A.2. Information about the Series.**

- **a. Name of Series:** Perkins Discovery Fund

- **b. EDGAR series identifier (if any):** S000038882

- **c. LEI of Series:** 5493001USSQK1PIP3P25

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $6888241.64

**Total Liabilities:** $20709.02

**Net Assets:** $6867532.62

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000119646 | 5.64%                | 4.49%                | 0.32%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-261100.76              | $650224.58                                 |
| Month 2  | $127704.80               | $183848.95                                 |
| Month 3  | $-25808.50               | $63541.25                                  |

### Schedule of Portfolio Investments

| Name                           | Title                            | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| DIGI INTL INC                  | Digi International, Inc.         | CUSIP: 253798102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6000 | NS      | $259740.00    | 3.78%             |  |  |  | No            |                  1 | On Loan: No      |
| EPLUS INC                      | EPlus Inc                        | CUSIP: 294268107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5000 | NS      | $438500.00    | 6.39%             |  |  |  | No            |                  1 | On Loan: No      |
| NEOGENOMICS INC                | NeoGenomics, Inc.                | CUSIP: 64049M209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22000 | NS      | $258720.00    | 3.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Vericel Corp.                  | Vericel Corp.                    | CUSIP: 92346J108<br>LEI: 54930076YM3PLTDR4B91 | Long             | EC               | CORP              | US        |      6000 | NS      | $216060.00    | 3.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Fidelity Government Portfolio    | CUSIP: 316175108<br>LEI: N/A                  | Long             | STIV             | RF                | US        |     35693 | NS      | $35692.98     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| ATRICURE INC                   | AtriCure, Inc.                   | CUSIP: 04963C209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7000 | NS      | $276920.00    | 4.03%             |  |  |  | No            |                  1 | On Loan: No      |
| AXOGEN INC                     | Axogen, Inc.                     | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     27000 | NS      | $883710.00    | 12.87%            |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | ANI Pharmaceuticals, Inc.        | CUSIP: 00182C103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6350 | NS      | $501269.00    | 7.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Cryoport Inc                   | CryoPort, Inc.                   | CUSIP: 229050307<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15000 | NS      | $144000.00    | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | BioLife Solutions, Inc.          | CUSIP: 09062W204<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12500 | NS      | $302250.00    | 4.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Veracyte, Inc.                   | CUSIP: 92337F107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14000 | NS      | $589400.00    | 8.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Natera, Inc.                     | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3250 | NS      | $744542.50    | 10.84%            |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Asure Software, Inc.             | CUSIP: 04649U102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23500 | NS      | $221370.00    | 3.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | OptimizeRX Corp.                 | CUSIP: 68401U204<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14000 | NS      | $171640.00    | 2.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Magnite, Inc.                    | CUSIP: 55955D100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20000 | NS      | $324600.00    | 4.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Exagen, Inc.                     | CUSIP: 30068X103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15000 | NS      | $91200.00     | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Inuvo, Inc.                      | CUSIP: 46122W303<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     37500 | NS      | $93000.00     | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Perion Network Ltd.              | CUSIP: M78673114<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11500 | NS      | $110170.00    | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | MDxHealth SA                     | CUSIP: 025927451<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     32500 | NS      | $116025.00    | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Tactile Systems Technology Inc | Tactile Systems Technology, Inc. | CUSIP: 87357P100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6500 | NS      | $188500.00    | 2.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Elutia Inc                       | CUSIP: 05479K106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     37500 | NS      | $25976.25     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Tela Bio Inc                     | CUSIP: 872381108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     64000 | NS      | $75520.00     | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Backblaze Inc                    | CUSIP: 05637B105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30000 | NS      | $139800.00    | 2.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | BUTTERFLY NETWORK INC            | CUSIP: 124155102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     60500 | NS      | $229900.00    | 3.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Skywater Technology Inc.         | CUSIP: 83089J108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14500 | NS      | $263320.00    | 3.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Owlet,Inc.                       | CUSIP: 69120X206<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10500 | NS      | $169995.00    | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-01-30

**Name of Applicant:** World Funds Trust

**Signature:** Ann MacDonald

**Name of Signer:** Ann MacDonald

**Title:** Principal Financial Officer